Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.380
+0.100 (4.39%)
At close: Apr 25, 2025, 4:00 PM
2.370
-0.010 (-0.42%)
After-hours: Apr 25, 2025, 6:42 PM EDT
Akebia Therapeutics Employees
Akebia Therapeutics had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$884,972
Profits / Employee
-$383,481
Market Cap
621.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AKBA News
- 22 days ago - Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa - GlobeNewsWire
- 23 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - GlobeNewsWire
- 5 weeks ago - JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
- 5 weeks ago - Akebia Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Akebia Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update - GlobeNewsWire